ALEC peer analysis
Alector (ALEC) against its competitors: price, today's move, 1-year return and market value side by side.
- ALEC's peers: ABOS (Acumen Pharmaceuticals), CRBP (Corbus), FATE (Fate Therapeutics), IRD (Opus Genetics), MOLN (Molecular Partners), NKTX (Nkarta), PEPG (PepGen), VOR (Vor Biopharma).
ALEC and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABOS Acumen Pharmaceuticals | $0.18 | -9.11% | -88.66% | $12.71M |
| CRBP Corbus | $2.09 | -14.17% | -82.32% | $43.07M |
| FATE Fate Therapeutics | $0.96 | -5.06% | -8.68% | $116.57M |
| IRD Opus Genetics | $3.87 | -5.17% | 108.01% | $373.95M |
| MOLN Molecular Partners | $2.67 | -6.82% | – | $102.16M |
| NKTX Nkarta | $1.15 | 2.68% | -35.75% | $82.37M |
| PEPG PepGen | $3.79 | -3.56% | -31.46% | $262.50M |
| VOR Vor Biopharma | $19.20 | 3.67% | 145.52% | $1.18B |
| ALEC Alector | $2.33 | 1.52% | 91.39% | $347.63M |